nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer
|
De Meerleer, Gert |
|
|
5 |
4 |
p. 428-429 |
artikel |
2 |
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
|
Salazar, Aina |
|
|
5 |
4 |
p. 460-463 |
artikel |
3 |
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate Cancer
|
Walz, Jochen |
|
|
5 |
4 |
p. 401-402 |
artikel |
4 |
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations
|
Hensley, Patrick J. |
|
|
5 |
4 |
p. 403-411 |
artikel |
5 |
Contents
|
|
|
|
5 |
4 |
p. iii-v |
artikel |
6 |
Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis” [Eur Urol Oncol 2021;4:927–42]
|
Laukhtina, Ekaterina |
|
|
5 |
4 |
p. 480-481 |
artikel |
7 |
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma
|
Lenfant, Louis |
|
|
5 |
4 |
p. 464-471 |
artikel |
8 |
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer
|
Cani, Andi K. |
|
|
5 |
4 |
p. 430-439 |
artikel |
9 |
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
|
Kawada, Tatsushi |
|
|
5 |
4 |
p. 390-400 |
artikel |
10 |
Editorial Board
|
|
|
|
5 |
4 |
p. i-ii |
artikel |
11 |
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
|
Stenzl, Arnulf |
|
|
5 |
4 |
p. 449-450 |
artikel |
12 |
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial
|
Gallioli, Andrea |
|
|
5 |
4 |
p. 440-448 |
artikel |
13 |
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
|
Weiner, Adam B. |
|
|
5 |
4 |
p. 377-387 |
artikel |
14 |
Managing Prostate Cancer Recurrence After Local Treatment: Balancing Benefits Against Risks in a Rapidly Changing Environment
|
Tombal, Bertrand |
|
|
5 |
4 |
p. 388-389 |
artikel |
15 |
Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups
|
Hurst, Rachel |
|
|
5 |
4 |
p. 412-419 |
artikel |
16 |
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
|
Martini, Alberto |
|
|
5 |
4 |
p. 451-459 |
artikel |
17 |
Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Kalampokis, Nikolaos |
|
|
5 |
4 |
p. 472-473 |
artikel |
18 |
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002
|
Guler, Ozan Cem |
|
|
5 |
4 |
p. 475-476 |
artikel |
19 |
Reply to Nikolaos Kalampokis, Nikolaos Grivas, Markos Karavitakis, and Henk van der Poel’s Letter to the Editor re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Morote, Juan |
|
|
5 |
4 |
p. 474 |
artikel |
20 |
Reply to Ozan Cem Guler and Cem Onal’s Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005
|
Pan, Jian |
|
|
5 |
4 |
p. 479 |
artikel |
21 |
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
|
Guler, Ozan Cem |
|
|
5 |
4 |
p. 477-478 |
artikel |
22 |
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study
|
Pan, Jian |
|
|
5 |
4 |
p. 420-427 |
artikel |